Appendix - CNIC

SCIENTIFIC REPORT ´09
Leon Latre M, Andes EM, Cordero A,
Pascual I, Vispe C, Laclaustra M,
Luengo E, Casasnovas JA.
Relationship Between Metabolic
Syndrome and Ischemic Heart Disease
Mortality in Spain.
Rev Esp Cardiol (2009)
62: 1469-72
IF: 2.880
Menke A, Fernandez-Real JM, Muntner
P, Guallar E.
The association of biomarkers of iron
status with peripheral arterial disease
in US adults.
BMC Cardiovasc Disord (2009)
9: 34
IF: n/a
Menke A, Muntner P, Silbergeld EK,
Platz EA, Guallar E.
Cadmium levels in urine and mortality
among U.S. adults.
Environ Health Perspect (2009)
117: 190-6
IF: 6.123
Miller ER 3rd, Guallar E.
Vitamin E supplementation: what's the
harm in that?
Clin Trials (2009)
6: 47-9
IF: 1.694
Miller ER 3rd, Juraschek SP, Appel LJ,
Madala M, Anderson CA, Bleys J,
Guallar E.
The effect of n-3 long-chain
polyunsaturated fatty acid
supplementation on urine protein
excretion and kidney function: metaanalysis
of clinical trials.
Am J Clin Nutr (2009)
89: 1937-45
IF: 6.740
Moore LV, Diez Roux AV, Nettleton JA,
Jacobs DR, Franco M.
Publications 2009
Fast-Food Consumption, Diet Quality,
and Neighborhood Exposure to Fast
Food: The Multi-Ethnic Study of
Atherosclerosis.
Am J Epidemiol (2009)
170: 29-36
IF: 5.454
Navas-Acien A, Silbergeld EK, Pastor-
Barriuso R, Guallar E.
Rejoinder: Arsenic Exposure and
Prevalence of Type 2 Diabetes:
Updated Findings From the National
Health Nutrition and Examination
Survey, 2003-2006.
Epidemiology (2009)
20: 816-20
IF: 5.406
Navas-Acien A, Tellez-Plaza M, Guallar
E, Muntner P, Silbergeld E, Jaar B,
Weaver V.
Blood Cadmium and Lead and Chronic
Kidney Disease in US Adults: A Joint
Analysis.
Am J Epidemiol (2009)
170: 1156-64
IF: 5.454
Navas-Acien A, Umans JG, Howard BV,
Goessler W, Francesconi KA,
Crainiceanu CM, Silbergeld EK, Guallar E.
Urine arsenic concentrations and
species excretion patterns in American
Indian communities over a 10-year
period: the Strong Heart Study.
Environ Health Perspect (2009)
117: 1428-33
IF: 6.123
Ordovas JM.
Cardiovascular diseases: integrating
genetics and the environment.
Nat Rev Cardiol (CNIC EDITION) (2009)
6: 49-53
IF: n/a
Smith CE, Arnett DK, Tsai MY, Lai CQ,
Parnell LD, Shen J, Laclaustra M,
Junyent M, Ordovas JM.
Physical inactivity interacts with an
endothelial lipase polymorphism to
modulate high density lipoprotein
cholesterol in the GOLDN study.
Atherosclerosis (2009)
206: 500-4
IF: 4.601
Vasan RS, Pencina MJ, Robins SJ,
Zachariah JP, Kaur G, D'Agostino RB,
Ordovas JM.
95
Appendix
Association of circulating cholesteryl
ester transfer protein activity with
incidence of cardiovascular disease in
the community.
Circulation (2009)
120: 2414-20
IF: 14.595
REGENERATIVE CARDIOLOGY
Bailey B, Izarra A, Alvarez R, Fischer
KM, Cottage CT, Quijada P, Diez-Juan
A, Sussman MA.
Cardiac stem cell genetic engineering
using the alpha MHC promoter.
Regen Med (2009)
4: 823-33
IF: 2.786
Cervera AM, Bayley JP, Devilee P,
McCreath KJ.
Inhibition of succinate dehydrogenase
dysregulates histone modifications in
mammalian cells.
Mol Cancer (2009)
8: 89
IF: 5.362
Gago N, Perez-Lopez V, Sanz-Jaka JP,
Cormenzana P, Eizaguirre I, Bernad A,
Izeta A.
Age-dependent depletion of human
skin-derived progenitor cells.
Stem Cells (2009)
27:1164-72
IF: 7.740
Galvez BG, Covarello D, Tolorenzi R,
Brunelli S, Dellavalle A, Crippa S,
Mohammed SA, Scialla L, Cuccovillo I,
Molla F, Staszewsky L, Maisano F,
Sampaolesi M, Latini R, Cossu G.
Human cardiac mesoangioblasts
isolated from hypertrophic
cardiomyopathies are greatly reduced in
proliferation and differentiation
potency.
Cardiovasc Res (2009)
83: 707-16
IF: 5.947